obexelimab   Click here for help

GtoPdb Ligand ID: 14594

Synonyms: XmAb5871
Immunopharmacology Ligand
Compound class: Antibody
Comment: Obexelimab (XmAb5871) is an anti-CD19 monoclonal antibody [3-4].
Click here for help
No information available.
Summary of Clinical Use Click here for help
Obexelimab (XmAb5871) was progressed as a clinical candidate.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05662241 A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease Phase 3 Interventional Zenas BioPharma (USA), LLC
NCT05786573 A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre) Phase 3 Interventional Zenas BioPharma (USA), LLC
NCT06559163 A Study of Obexelimab in Patients With Systemic Lupus Erythematosus Phase 2 Interventional Zenas BioPharma (USA), LLC
NCT06564311 A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone) Phase 2 Interventional Zenas BioPharma (USA), LLC
NCT02725476 Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease (RD) Phase 2 Interventional Xencor, Inc.
NCT02725515 A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus Phase 2 Interventional Xencor, Inc.